Cellens
Cellens is an innovative cancer diagnostic company that leverages mechanobiology and machine learning to provide non-invasive cancer detection through its Octosense platform. The company focuses on single-cell biophysical markers to identify cancer cells accurately and efficiently, making it a leader in the field of cancer diagnostics. With a strong foundation in research from Tufts University, Cellens aims to transform cancer screening and monitoring, particularly for bladder cancer, and is supported by a team of experts in mechanobiology and engineering. The company has received recognition for its groundbreaking work and is actively seeking partnerships to expand its impact in the healthcare sector.
Cellens
Cellens is an innovative cancer diagnostic company that leverages mechanobiology and machine learning to provide non-invasive cancer detection through its Octosense platform. The company focuses on single-cell biophysical markers to identify cancer cells accurately and efficiently, making it a leader in the field of cancer diagnostics. With a strong foundation in research from Tufts University, Cellens aims to transform cancer screening and monitoring, particularly for bladder cancer, and is supported by a team of experts in mechanobiology and engineering. The company has received recognition for its groundbreaking work and is actively seeking partnerships to expand its impact in the healthcare sector.